{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:07:00Z","timestamp":1794920820427,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bacterial infections are the most frequent complications in patients with malignancy, and the epidemiology of nosocomial infections among cancer patients has changed over time. This study aimed to evaluate the characteristics, antibiotic resistance patterns, and prognosis of nosocomial infections due to multidrug-resistant (MDR) bacteria in cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective observational study analyzed cancer patients with nosocomial infections caused by MDR from August 2013 to May 2019. The extracted clinical data were recorded in a standardized form and compared based on the survival status of the patients after infection and during hospitalization. The data were analyzed using independent samples t-test, Chi-square test, and binary logistic regression.\n                      <jats:italic>P<\/jats:italic>\n                      -values &lt;\u20090.05 were considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One thousand eight patients developed nosocomial infections during hospitalization, with MDR strains detected in 257 patients. Urinary tract infection (38.1%), respiratory tract infection (26.8%), and bloodstream infection (BSI) (12.5%) were the most common infection types. Extended-spectrum \u03b2-lactamase producing Enterobacteriaceae (ESBL-PE) (72.8%) members were the most frequently isolated MDR strains, followed by\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      (11.7%), and\n                      <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                      (6.2%). The results of multivariate regression analysis revealed that smoking history, intrapleural\/abdominal infusion history within 30\u2009days, the presence of an indwelling urinary catheter, length of hospitalization, and hemoglobin were independent factors for in-hospital mortality in the study population. The isolated MDR bacteria exhibited high rates of sensitivity to amikacin, meropenem, and imipenem.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The burden of nosocomial infections due to MDR bacteria is considerably high in oncological patients, with ESBL-PE being the most predominant causative pathogen. Our findings suggest that amikacin and carbapenems actively against more than 89.7% of MDR isolates. The precise management of MDR bacterial infections in cancer patients may improve the prognosis of these individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05181-6","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T09:03:52Z","timestamp":1593421432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China"],"prefix":"10.1186","volume":"20","author":[{"given":"Ai-Min","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Di","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"issue":"6","key":"5181_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ijantimicag.2016.08.021","volume":"48","author":"M Alevizakos","year":"2016","unstructured":"Alevizakos M, Karanika S, Detsis M, et al. Colonisation with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;48(6):647\u201354. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.08.021.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"5181_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/21505594.2016.1141161","volume":"7","author":"C Gudiol","year":"2016","unstructured":"Gudiol C, Aguado JM, Carratala J. Bloodstream infections in patients with solid tumors. Virulence. 2016;7(3):298\u2013308. https:\/\/doi.org\/10.1080\/21505594.2016.1141161.","journal-title":"Virulence."},{"issue":"6","key":"5181_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1470-2045(09)70069-5","volume":"10","author":"M Kamboj","year":"2009","unstructured":"Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. The Lancet Oncology. 2009;10(6):589\u201397. https:\/\/doi.org\/10.1016\/S1470-2045(09)70069-5.","journal-title":"The Lancet Oncology"},{"issue":"6","key":"5181_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jinf.2016.04.003","volume":"72","author":"JS Brand","year":"2016","unstructured":"Brand JS, Colzani E, Johansson ALV, et al. Infection-related hospitalizations in breast cancer patients: risk and impact on prognosis. J Inf Secur. 2016;72(6):650\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2016.04.003.","journal-title":"J Inf Secur"},{"issue":"1","key":"5181_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1186\/s12879-019-4448-7","volume":"19","author":"G Dimomicronpoulos","year":"2019","unstructured":"Dimomicronpoulos G, Rovina N, Patrani M, et al. Past history of stage I\/II solid tumor malignancy impacts considerably on sepsis mortality: a propensity score matching analysis from the hellenic sepsis study group. BMC Infect Dis. 2019;19(1):831. https:\/\/doi.org\/10.1186\/s12879-019-4448-7.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5181_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36(9):1103\u201310. https:\/\/doi.org\/10.1086\/374339.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5181_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","volume":"19","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19(5):474\u20139. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03879.x.","journal-title":"Clin Microbiol Infect"},{"key":"5181_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13756-019-0599-y","volume":"8","author":"T Xiao","year":"2019","unstructured":"Xiao T, Yang K, Zhou Y, et al. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016. Antimicrob Resist Infect Control. 2019;8:144. https:\/\/doi.org\/10.1186\/s13756-019-0599-y.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"5181_CR9","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","volume":"91","author":"C Cattaneo","year":"2012","unstructured":"Cattaneo C, Antoniazzi F, Casari S, et al. P. aeruginosa bloodstream infections among hematological patients: an old or new question? Ann Hematol. 2012;91(8):1299\u2013304. https:\/\/doi.org\/10.1007\/s00277-012-1424-3.","journal-title":"Ann Hematol"},{"issue":"4","key":"5181_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/21505594.2016.1213472","volume":"8","author":"SM Pouch","year":"2017","unstructured":"Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8(4):391\u2013402. https:\/\/doi.org\/10.1080\/21505594.2016.1213472.","journal-title":"Virulence."},{"key":"5181_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/IDR.S144314","volume":"10","author":"W Katip","year":"2017","unstructured":"Katip W, Uitrakul S, Oberdorfer P. Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients. Infect Drug Resist. 2017;10:293\u20138. https:\/\/doi.org\/10.2147\/IDR.S144314.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"5181_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1586\/14787210.2014.920253","volume":"12","author":"C Gudiol","year":"2014","unstructured":"Gudiol C, Carratala J. Antibiotic resistance in cancer patients. Expert Rev Anti-Infect Ther. 2014;12(8):1003\u201316. https:\/\/doi.org\/10.1586\/14787210.2014.920253.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"5181_CR13","doi-asserted-by":"publisher","unstructured":"Perdikouri EIA, Arvaniti K, Lathyris D, et al. Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis. Microorganisms. 2019;7(9). https:\/\/doi.org\/10.3390\/microorganisms7090277.","DOI":"10.3390\/microorganisms7090277"},{"issue":"4","key":"5181_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/cid\/ciq147","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427\u201331. https:\/\/doi.org\/10.1093\/cid\/ciq147.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5181_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","volume":"98","author":"M Kochanek","year":"2019","unstructured":"Kochanek M, Schalk E, von Bergwelt-Baildon M, et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the infectious diseases working party (AGIHO) and intensive care working party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2019;98(5):1051\u201369. https:\/\/doi.org\/10.1007\/s00277-019-03622-0.","journal-title":"Ann Hematol"},{"issue":"11","key":"5181_CR16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","volume":"96","author":"WJ Heinz","year":"2017","unstructured":"Heinz WJ, Buchheidt D, Christopeit M, et al. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2017;96(11):1775\u201392. https:\/\/doi.org\/10.1007\/s00277-017-3098-3.","journal-title":"Ann Hematol"},{"issue":"5","key":"5181_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"3","key":"5181_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jac\/dkq494","volume":"66","author":"C Gudiol","year":"2011","unstructured":"Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66(3):657\u201363. https:\/\/doi.org\/10.1093\/jac\/dkq494.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5181_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0195-6701(98)90237-7","volume":"39","author":"MJ Crowe","year":"1998","unstructured":"Crowe MJ, Cooke EM. Review of case definitions for nosocomial infection \u2014 towards a consensus. J Hosp Infect. 1998;39(1):3\u201311. https:\/\/doi.org\/10.1016\/S0195-6701(98)90237-7.","journal-title":"J Hosp Infect"},{"issue":"2","key":"5181_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/1076629041310055","volume":"10","author":"CS Zinn","year":"2004","unstructured":"Zinn CS, Westh H, Rosdahl VT. An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist. 2004;10(2):160\u20138. https:\/\/doi.org\/10.1089\/1076629041310055.","journal-title":"Microb Drug Resist"},{"issue":"3","key":"5181_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jac\/dkw513","volume":"72","author":"ZR Palacios-Baena","year":"2017","unstructured":"Palacios-Baena ZR, Gutierrez-Gutierrez B, De Cueto M, et al. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2017;72(3):906\u201313. https:\/\/doi.org\/10.1093\/jac\/dkw513.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5181_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijantimicag.2016.11.009","volume":"49","author":"CY Chen","year":"2017","unstructured":"Chen CY, Tien FM, Sheng WH, et al. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical Centre in northern Taiwan, 2008-2013. Int J Antimicrob Agents. 2017;49(3):272\u201381. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.009.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5181_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmi.2018.07.026","volume":"25","author":"P Puerta-Alcalde","year":"2019","unstructured":"Puerta-Alcalde P, Cardozo C, Suarez-Lledo M, et al. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect. 2019;25(4):447\u201353. https:\/\/doi.org\/10.1016\/j.cmi.2018.07.026.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5181_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841X.2013.875515","volume":"42","author":"LM Biehl","year":"2016","unstructured":"Biehl LM, Schmidt-Hieber M, Liss B, et al. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - review of the literature from a clinical perspective. Crit Rev Microbiol. 2016;42(1):1\u201316. https:\/\/doi.org\/10.3109\/1040841X.2013.875515.","journal-title":"Crit Rev Microbiol"},{"issue":"2","key":"5181_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10096-014-2233-5","volume":"34","author":"MP Freire","year":"2015","unstructured":"Freire MP, Pierrotti LC, Filho HH, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients. Eur J Clin Microbiol Infect Dis. 2015;34(2):277\u201386. https:\/\/doi.org\/10.1007\/s10096-014-2233-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"5181_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1089\/mdr.2015.0032","volume":"21","author":"LH Nazer","year":"2015","unstructured":"Nazer LH, Kharabsheh A, Rimawi D, et al. Characteristics and outcomes of Acinetobacter baumannii infections in critically ill patients with Cancer: a matched case-control study. Microb Drug Resist. 2015;21(5):556\u201361. https:\/\/doi.org\/10.1089\/mdr.2015.0032.","journal-title":"Microb Drug Resist"},{"key":"5181_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fcimb.2015.00011","volume":"5","author":"R Moghnieh","year":"2015","unstructured":"Moghnieh R, Estaitieh N, Mugharbil A, et al. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Front Cell Infect Microbiol. 2015;5:11. https:\/\/doi.org\/10.3389\/fcimb.2015.00011.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"5181_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri2530","volume":"9","author":"MR St\u00e4mpfli","year":"2009","unstructured":"St\u00e4mpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009;9(5):377\u201384. https:\/\/doi.org\/10.1038\/nri2530.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5181_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhin.2012.10.012","volume":"83","author":"K Hussein","year":"2013","unstructured":"Hussein K, Raz-Pasteur A, Finkelstein R, et al. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83(4):307\u201313. https:\/\/doi.org\/10.1016\/j.jhin.2012.10.012.","journal-title":"J Hosp Infect"},{"issue":"4","key":"5181_CR30","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jac\/dkv414","volume":"71","author":"Y Fraenkel-Wandel","year":"2016","unstructured":"Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, et al. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016;71(4):1083\u20137. https:\/\/doi.org\/10.1093\/jac\/dkv414.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5181_CR31","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s13277-015-4042-6","volume":"37","author":"LN Zhang","year":"2016","unstructured":"Zhang LN, Tang J, Lan XW, et al. Pretreatment anemia and survival in nasopharyngeal carcinoma. Tumour Biol. 2016;37(2):2225\u201331. https:\/\/doi.org\/10.1007\/s13277-015-4042-6.","journal-title":"Tumour Biol"},{"key":"5181_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1479-5876-7-14","volume":"7","author":"HM Ashour","year":"2009","unstructured":"Ashour HM, El-Sharif A. Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med. 2009;7:14. https:\/\/doi.org\/10.1186\/1479-5876-7-14.","journal-title":"J Transl Med"},{"issue":"5","key":"5181_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jmii.2011.01.035","volume":"44","author":"CC Huang","year":"2011","unstructured":"Huang CC, Wu CJ, Wang LR, et al. Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan. J Microbiol Immunol Infect. 2011;44(5):376\u201381. https:\/\/doi.org\/10.1016\/j.jmii.2011.01.035.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"5181_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"X-Z Li","year":"2015","unstructured":"Li X-Z, Pl\u00e9siat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337\u2013418. https:\/\/doi.org\/10.1128\/CMR.00117-14.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"5181_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2014.05.090","volume":"453","author":"J Sun","year":"2014","unstructured":"Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 2014;453(2):254\u201367. https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.090.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5181_CR36","first-page":"102","volume":"18","author":"MR Arabestani","year":"2015","unstructured":"Arabestani MR, Rajabpour M, Yousefi Mashouf R, et al. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Archives Iranian Med. 2015;18(2):102\u20138.","journal-title":"Archives Iranian Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05181-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T19:11:35Z","timestamp":1624907495000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05181-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5181"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05181-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23185\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23185\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23185\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"27 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University (No: XJTU1AF2020LSK-049). Waiving of informed consent was obtained due to the retrospective noninterventional study design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}